

CAMBRIDGE IMPACT TECHNOLOGY
Cambridge Impact Technology is part of the Richmond Partners Group of Companies
We invest in early stage healthcare and life sciences technology driven impact focused companies
OUR INVESTMENT STRATEGY
We invest in early stage healthcare and life sciences technology driven impact focused companies
​
We only look for high growth and high return strategies
​
With a high ROI requirement we are highly selective of our investments
​
We are very hands on and work closely with the founding team to find truly unique opportunities
​
We are smart money and often the first money for the company, we help to introduce discipline and rigor in early rounds
​
We use our sector expertise to carefully identify and only back ultra-high potential companies that have a real probability of becoming unicorns in the sector
​
We look for true impact and only invest responsibly to crate a better, more prosperous world full of healthy people



OUR INVESTMENT METRICS
OUR TARGET BUSINESSES
We invest in different businesses within the healthcare and life-sciences sectors
​
Every business is carefully selected and ideally may have the following:
​
Market
-
Healthcare, Life Sciences, Fitness, Insurance, Lifestyle, Wellness, Social care and related sectors
-
Pre-identified Exit opportunity through a strategic sale short-to-medium term (12-24months)
-
Ready for disruption segment of the market
-
Already educated / part educated market
-
Low barriers to entry / New barriers can be put in place for strategic advantages
Product / Service
-
Technology / Innovation / IP driven
-
Fast-growth potential / Disruptive potential
-
Leveraging new tech: e.g. AI / Platform / SaaS / AR / VR Technology / Blockchain
-
Higley valued comparable products
Founder / Team
-
Driven, hungry and focused founder / team
-
Good at promoting the business
-
Good in front of investors
-
Ability to take advice / can work with
Operating Model
-
Rapidly scalable model
-
Measurable Impact
-
Low capex model: e.g. Platform businesses / Subscription models



OUR INVESTMENT MODEL
Our strategy is predicated on investing in early stage companies with high potential: we typically bring smart capital shortly after the company inception and we work closely with the founders, helping them scaling up and shaping their business model
​
Our main key success factors are:
​
-
Deep healthcare and life sciences sector expertise, which allow us to select innovative ideas and help the entrepreneurs navigate those complex and constantly evolving sectors
-
Strong network and governance expertise, which allow us to steer the business into the right direction and give entrepreneurs access to capital to scale further
-
Impact focus, which will allow us to select ventures and implement a strategy promoting and improving health and social care systems